Certara
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Pennsylvania, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
4 Radnor Corporate Ctr Ste 350, Radnor, ...Phone Number
(609) 716-7900Website
www.certara.comRevenue
$419.7 MillionStock Symbol
CERTIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
5
6
1
2
2
3
About Certara
Certara provides software, AI-driven platforms, and scientific consulting services used across the drug development lifecyclefrom discovery and preclinical modeling to clinical trials, regulatory submissions, and market access. Its core strength is model-informed drug development (MIDD) and biosimulation technologies that help predict drug behavior and optimize clinical outcomes.Explore more
Certara Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Certara your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Certara, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Certara
Click to see if Certara had a recent Job posting/layoffs
Check out if Certara is spiking on competitors!
Check if Certara has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Certara launches new products
Funding: Get notified immidiatlly once Certara has new funding data
Earning: See what the market has to say on Certara recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Certara as Masked Content
Find 3 more new buyers
Compare Similar Companies to Certara
Compare insights from companies similar to Certara, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Certara is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Certara is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Certara.
Certara financials insights
Gather financial insights about Certara, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$668M
2021
Stock Offering
$310M
2022
Private Equity
$449M
2026
Private Equity
$8.6M
Certara Tech Stack
A closer look at the technologies used by Certara
See more technologies
Most Recent Scoops
Open Position
Open Position
Person-Based
Stake & Stock Ownership, Finance
Lateral Move
Executive Move
Executive Moves, Lateral Move
Left Company
Executive Move
Executive Moves, Left Company
Certara News & Media
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
RADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026 before market open on Tuesday, August 4th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. (“Certara” or the “Company”) (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
Certara partners with NVIDIA to advance its open, integrated AI platform for drug discovery and development with the BioNeMo Agent Toolkit
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Certara
Sign Up For FreeTo access detailed company insights
Certara provides software, AI-driven platforms, and scientific consulting services used across the drug development lifecyclefrom discovery and preclinical modeling to clinical trials, regulatory submissions, and market access. Its core strength is model-informed drug development (MIDD) and biosimulation technologies that help predict drug behavior... Read More
